Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan Endress

Hand Surgery Lone Tree, CO Medical Doctor

NPI 1457549446 CMS profile 338722

10535 Park Meadows Blvd Ste 350, Lone Tree, CO 80124

Open in the dashboard

General payments

$79,737

174 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$100,000

4 holdings reported · through program year 2025

Through program year 2025, Ryan Endress of Lone Tree, CO is reported in the CMS Open Payments database as having received $79,737 across 174 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $100,000 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,683 45
2024 General $3,647 26
2023 General $14,611 23
2022 General $51,844 33
2021 General $4,043 25
2020 General $1,173 8
2019 General $735 14
2025 Ownership $25,000 1
2024 Ownership $25,000 1
2023 Ownership $25,000 1
2022 Ownership $25,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Endress
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Ryan Endress were reported at $3,683. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Ryan Endress Hand Surgery median Middle half National median
2019 $735 $383 $106–$1,905 $163
2020 $1,173 $172 $51–$1,268 $114
2021 $4,043 $263 $71–$1,591 $132
2022 $51,844 $336 $87–$1,938 $149
2023 $14,611 $233 $81–$1,114 $160
2024 $3,647 $258 $88–$1,203 $164
2025 $3,683 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Valencia Technologies Corporation $49,474 7 payments
  2. AxoGen $18,228 28 payments
  3. Access Pro Medical, LLC $3,058 12 payments
  4. In2Bones USA, LLC $2,310 10 payments
  5. AbbVie, Inc. $2,002 11 payments
  6. Integra LifeSciences Corporation $1,041 32 payments
  7. Avita Medical Americas, LLC $586 8 payments
  8. Smith+Nephew, Inc. $400 11 payments
  9. Kerecis Limited $392 4 payments
  10. Musculoskeletal Transplant Foundation Inc. $292 2 payments
  11. Other $1,954 49 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $64,313 11 payments
  2. Food and Beverage $8,017 142 payments
  3. Travel and Lodging $5,204 12 payments
  4. Royalty or License $2,204 9 payments
Products named General payments · program years 2019–2025
  1. eCoin Device Kit $49,474 7 payments
  2. Avance Nerve Graft $18,081 26 payments
  3. AXOGUARD NERVE PROTECTOR $15,067 14 payments
  4. AxoGuard Nerve Connector $15,067 14 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS $3,933 19 payments
  6. Matriderm $3,058 12 payments
  7. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $1,931 8 payments
  8. REVOLVE $1,931 8 payments
  9. CoLink $1,320 4 payments
  10. AXOGUARD NERVE CAP $1,063 1 payment
  11. Other $11,741 245 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$92,717

Medicare's payments for the services billed

Medicare patients

90

Average age 69

Services billed

668

50 women, 40 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 44%
Depression 39%
Ischemic heart disease 31%
COPD 27%
Diabetes 26%
Chronic kidney disease 26%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIAFLEX
  • Endo USA, Inc. $20
  • Endo Pharmaceuticals Inc. $19
$39 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

174 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record